Loading clinical trials...
Loading clinical trials...
To determine the effect of an intestinal adsorbent on hydrogen and methane breath levels in patients who have been on long term PPI therapy reporting reflux and abdominal symptoms at baseline.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Dr Anthony Hobson
NCT05514769 · Proximal Gastric Adenocarcinoma, Gastric Cancer, and more
NCT04411823 · Gastroesophageal Reflux, Sleeve Gastrectomy, and more
NCT02616302 · Gastroesophageal Reflux Disease (GERD)
NCT07145580 · Food Intolerance Syndromes, Small Intestinal Bacterial Overgrowth Syndrome (SIBO), and more
NCT07121803 · Ineffective Esophageal Motility, GERD (Gastroesophageal Reflux Disease)
The Functional Gut Clinic
Manchester
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions